Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Actinogen Medical ( (AU:ACW) ) has shared an announcement.
Actinogen Medical Limited has announced the quotation of 330,397 ordinary fully paid securities on the Australian Securities Exchange (ASX), effective August 29, 2025. This move reflects the company’s ongoing efforts to enhance its financial position and market presence, potentially impacting its operations and stakeholder interests by increasing liquidity and investor confidence.
More about Actinogen Medical
Actinogen Medical Limited operates in the biotechnology industry, focusing on the development of innovative therapies for neurological and neurodegenerative diseases. The company’s primary products and services are centered around advancing treatments that address cognitive decline and other brain-related conditions.
Average Trading Volume: 3,642,328
Technical Sentiment Signal: Hold
Current Market Cap: A$92.08M
For an in-depth examination of ACW stock, go to TipRanks’ Overview page.